Want to see CTRE full AI Analyst Report?
Top Page
CareTrust REIT
(NYSE:CTRE)
Select Model
Select Model
Rating:81Outperform
Price Target:
$48.00
▲(10.98% Upside)
Action:Reiterated
Date:08/07/26
CTRE scores well primarily on financial performance—strong growth, very high margins, and standout free cash flow alongside a materially improved leverage profile. The latest earnings call reinforces this strength with raised guidance and strong liquidity/capital access, partially offset by execution/market risks (SHOP competition, reliance on equity forwards and guidance assumptions). Technicals are more neutral-to-soft near term, and valuation is only moderate given a ~26.7 P/E despite a ~3.46% dividend yield.
Positive Factors
Free Cash Flow Strength
Sustained, high free cash flow (TTM $519M) indicates durable internal funding for dividends, acquisitions, and debt flexibility. With FCF running ~97% of net income, earnings are backed by cash, reducing reliance on volatile external capital and supporting long-term payout and reinvestment strategies.
Negative Factors
Reliance on Unsettled Equity Forwards
Heavy reliance on unsettled forward equity proceeds to fund guidance and investments creates execution risk if market conditions or settlement mechanics change. Over the medium term this can compress growth or force higher-cost financing, making funding assumptions less reliable.
Read all positive and negative factors
Positive Factors
Negative Factors
Free Cash Flow Strength
Sustained, high free cash flow (TTM $519M) indicates durable internal funding for dividends, acquisitions, and debt flexibility. With FCF running ~97% of net income, earnings are backed by cash, reducing reliance on volatile external capital and supporting long-term payout and reinvestment strategies.
Read all positive factors
CareTrust REIT (CTRE) vs. SPDR S&P 500 ETF (SPY)
Market Cap
$9.91B
Dividend Yield3.46%
Average Volume (3M)2.86M
Price to Earnings (P/E)26.7
Beta (1Y)0.20
Revenue Growth58.48%
EPS Growth70.32%
CountryUS
Employees43
SectorReal Estate
Sector Strength53
IndustryREIT - Healthcare Facilities
Share Statistics
EPS (TTM)1.59
Shares Outstanding236,240,230
10 Day Avg. Volume2,449,187
30 Day Avg. Volume2,860,777
Financial Highlights & Ratios
PEG Ratio0.25
Price to Book (P/B)1.82
Price to Sales (P/S)15.45
P/FCF Ratio19.43
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda<0.01
Forecast
1Y Price Target
$46.71Price Target Upside8.01% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering7
EPS Forecast (FY)1.5
Revenue Forecast (FY)$500.01M
CareTrust REIT Business Overview & Revenue Model
Company Description
CareTrust REIT, Inc. operates as a self-managed, publicly traded real estate investment trust. The company specializes in the ownership, acquisition, development, and leasing of various healthcare properties, including skilled nursing facilities, ...
How the Company Makes Money
CareTrust REIT primarily makes money by collecting contractual rent from healthcare operators that lease its properties. Its core revenue stream is lease income generated from long-term net leases, under which tenants are generally responsible for...
CareTrust REIT Earnings Call Summary
Earnings Call Date:Aug 06, 2026
(Q2-2026)
| % Change Since: |
Next Earnings Date:Nov 11, 2026
Earnings Call Sentiment Positive
The call was strongly positive on operational and financial performance: record quarterly investments, robust YTD deployment (~$1.5B), double-digit per-share growth guidance, materially higher normalized FFO/FAD and conservative leverage with ample liquidity. Offsetting items are focused and tactical: competitive pressures and cap rate compression in the SHOP market, modest pricing premium on a large U.K. buy, reliance on unsettled equity forward proceeds and certain guidance assumptions, and multi-year uncertainty around financing receivable purchase options. Overall the strengths (record investment activity, significant FFO/FAD growth, strong balance sheet and operator quality) materially outweigh the select execution and market risks discussed.Positive Updates
Record Quarterly and Year-to-Date Investments
Closed approximately $900 million of investments in Q2 at a blended stabilized yield of 8.9% (single largest investment quarter excluding M&A). Since June 30, an additional ~$308 million closed at ~7.8% yield. Year-to-date investments total approximately $1.5 billion.
Negative Updates
SHOP: Competitive Pressure and Cap Rate Compression
Increased private-market entrant activity and competition in the SHOP space has compressed cap rates and made it difficult to secure attractive risk-adjusted returns. Management noted missing some SHOP deals primarily on price and that SHOP transactions have become more competitive.
Read all updates
Q2-2026 Updates
Positive
Negative
Record Quarterly and Year-to-Date Investments
Closed approximately $900 million of investments in Q2 at a blended stabilized yield of 8.9% (single largest investment quarter excluding M&A). Since June 30, an additional ~$308 million closed at ~7.8% yield. Year-to-date investments total approximately $1.5 billion.
Read all positive updates
Company Guidance
CareTrust raised full-year 2026 guidance, now projecting normalized FFO per share of $2.03–$2.06 and normalized FAD per share of $2.01–$2.04 (midpoint implying ~16.2% FFO/share and ~15.1% FAD/share growth vs. 2025) based on a weighted average diluted share count of 233 million; the outlook assumes no new investments/loans/dispositions or debt/equity issuances beyond year‑to‑date activity, 2.5% inflation-based rent escalators on long‑term triple‑net leases, $147 million of loans to be repaid during the year (≈$104 million received to date), and no material change in GBP/USD. The company noted ample liquidity to fund guidance with roughly $1.4 billion available (≈$90 million cash, $605 million revolver availability on a $1.2 billion facility, ≈$671 million unsettled equity forwards and ≈$785.8 million ATM capacity), a net debt to annualized normalized run‑rate EBITDA of 1.0x, fixed charge coverage of 9.9x, and no scheduled debt maturities before 2028.CareTrust REIT Financial Statement Overview
Summary
Income Statement
86
Very Positive
Balance Sheet
88
Very Positive
Cash Flow
91
Very Positive
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 543.45M | 476.59M | 228.26M | 198.60M | 187.51M | 190.19M |
| Gross Profit | 423.41M | 281.79M | 214.71M | 189.01M | 178.13M | 186.62M |
| EBITDA | 523.78M | 462.08M | 211.54M | 145.80M | 72.88M | 151.05M |
| Net Income | 355.40M | 320.54M | 125.08M | 53.73M | -7.51M | 71.98M |
Balance Sheet | ||||||
| Total Assets | 5.93B | 5.15B | 3.44B | 2.08B | 1.62B | 1.64B |
| Cash, Cash Equivalents and Short-Term Investments | 49.27M | 198.04M | 213.82M | 294.45M | 13.18M | 19.89M |
| Total Debt | 1.21B | 894.22M | 396.93M | 595.60M | 719.50M | 673.40M |
| Total Liabilities | 1.43B | 1.09B | 507.63M | 666.12M | 771.41M | 725.09M |
| Stockholders Equity | 4.49B | 4.04B | 2.91B | 1.42B | 849.37M | 915.76M |
Cash Flow | ||||||
| Free Cash Flow | 518.55M | 379.04M | 236.20M | 143.79M | 137.12M | 150.86M |
| Operating Cash Flow | 537.35M | 394.03M | 244.25M | 154.77M | 144.41M | 156.87M |
| Investing Cash Flow | -1.73B | -1.46B | -1.49B | -267.81M | -127.40M | -192.63M |
| Financing Cash Flow | 963.53M | 1.05B | 1.17B | 394.32M | -23.73M | 36.74M |
CareTrust REIT Technical Analysis
Positive
43.25
Price Trends
40.02
Positive
39.44
Positive
37.98
Positive
Market Momentum
0.24
Positive
49.43
Neutral
30.99
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For CTRE, the sentiment is Positive. The current price of 43.25 is above the 20-day moving average (MA) of 41.84, above the 50-day MA of 40.02, and above the 200-day MA of 37.98, indicating a neutral trend. The MACD of 0.24 indicates Positive momentum. The RSI at 49.43 is Neutral, neither overbought nor oversold. The STOCH value of 30.99 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for CTRE.
CareTrust REIT Risk Analysis
CareTrust REIT disclosed 49 risk factors in its most recent earnings report. CareTrust REIT reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks
CareTrust REIT Peers Comparison
UnderperformOutperform
Sector (65)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | $9.91B | 26.71 | 8.54% | 3.35% | 58.48% | 70.32% | |
74 Outperform | $15.34B | 17.52 | 16.51% | 5.18% | 15.18% | 72.69% | |
72 Outperform | $3.72B | 24.65 | 9.88% | 4.57% | 16.91% | -1.91% | |
66 Neutral | $11.60B | 95.47 | 5.87% | 1.74% | 12.24% | ― | |
65 Neutral | $2.17B | 12.19 | 3.79% | 4.94% | 3.15% | 1.96% | |
65 Neutral | $5.34B | 32.87 | 2.31% | 5.37% | 13.50% | 7.25% | |
63 Neutral | $7.20B | -80.10 | -1.94% | 4.49% | -6.44% | 46.41% |
* Real Estate Sector Average
CTRE
CareTrust REIT
41.22
9.62
30.43%
NHI
National Health Investors
75.30
3.49
4.85%
OHI
Omega Healthcare
48.46
10.57
27.89%
SBRA
Sabra Healthcare REIT
21.04
3.52
20.07%
HR
Healthcare Realty Trust
19.97
4.10
25.85%
AHR
American Healthcare REIT, Inc.
56.74
17.22
43.56%
CareTrust REIT Corporate Events
Business Operations and StrategyDividendsFinancial Disclosures
CareTrust REIT Raises 2026 Guidance After Strong Quarter
Positive
Aug 6, 2026
CareTrust REIT reported strong operating results for the quarter ended June 30, 2026, highlighted by net income of $89.0 million, or $0.38 per diluted share, up 9% year over year, and double-digit gains in Normalized FFO and FAD per share to $0.51...
Business Operations and StrategyPrivate Placements and Financing
CareTrust REIT Completes Upsized Public Equity Offering
Positive
May 21, 2026
On May 18, 2026, CareTrust REIT, Inc. and its operating partnership entered into an underwriting agreement with Wells Fargo Securities and J.P. Morgan Securities for a public equity offering of 12,500,000 common shares, plus an option for 1,875,00...
Business Operations and StrategyPrivate Placements and Financing
CareTrust REIT Launches Large Forward Equity Offering
Positive
May 20, 2026
On May 18, 2026, CareTrust REIT entered into an underwriting agreement with Wells Fargo and J.P. Morgan to facilitate a public offering of 12,500,000 common shares, with an option for underwriters to purchase up to an additional 1,875,000 shares a...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.